Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PHLPP2 | Q6ZVD8 | 2/20 | 0.74 |
| ▸ | GNG2 | P59768 | 5/20 | 0.71 |
| ▸ | GNB1 | P62873 | 5/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.62 |
| ▸ | P2RY2 | P41231 | 8/20 | 0.60 |
| ▸ | P2RY4 | P51582 | 8/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | P2RY12 | Q9H244 | 5/20 | 0.56 |
| ▸ | P2RY6 | Q15077 | 3/20 | 0.56 |
| ▸ | ENTPD1 | P49961 | 2/20 | 0.56 |
| ▸ | MET | P08581 | 2/20 | 0.55 |
| ▸ | HGF | P14210 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29439077 | 0.90 | P2RY2 (0.74) | P2RY2P2RY4P2RY12P2RY6ENTPD1 | |
| SCHEMBL2854183 | 0.90 | P2RY2 (0.74) | P2RY2P2RY4P2RY12P2RY6ENTPD1 | |
| SCHEMBL13021512 | 0.87 | GNG2 (0.92) | PHLPP2GNG2GNB1CYP1A2CYP2C9 | |
| SCHEMBL13316759 | 0.86 | P2RY12 (0.56) | PHLPP2GNG2GNB1P2RY2P2RY4 | |
| SCHEMBL29666889 | 0.85 | PHLPP2 (1.00) | PHLPP2GNG2GNB1CYP1A2CYP2C9 | |
| SCHEMBL9173299 | 0.85 | PHLPP2 (1.00) | PHLPP2GNG2GNB1CYP1A2CYP2C9 | |
| SCHEMBL2854079 | 0.84 | PHLPP2 (0.98) | PHLPP2GNG2GNB1CYP1A2CYP2C9 | |
| SCHEMBL9137161 | 0.83 | GNG2 (0.82) | PHLPP2GNG2GNB1CYP1A2CYP2C9 | |
| SCHEMBL2779595 | 0.83 | GNG2 (1.00) | PHLPP2GNG2GNB1CYP1A2CYP2C9 | |
| SCHEMBL13213975 | 0.83 | GNG2 (0.86) | PHLPP2GNG2GNB1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2546309-B1 | ANTHRAPYRIDONE SULPHONIC ACID COMPOUNDS, PREPARATION AND USE THEREOF | UNIV DALIAN TECH (CN) | 2016-06-01 | — | — | EP | disclosed |
| US-20150119356-A1 | Ophthalmic Viscoelastic Device | CARL ZEISS MEDITEC AG (DE) | 2015-04-30 | — | — | US | disclosed |
| US-8968453-B2 | Anthrapyridone sulfonic acid compounds and their preparation methods and applications | Zhuhai Ninestar Management Co., Ltd. (CN) | 2015-03-03 | — | — | US | disclosed |
| US-8968453-B2 | Anthrapyridone sulfonic acid compounds and their preparation methods and applications | Zhuhai Ninestar Management Co., Ltd. (CN) | 2015-03-03 | — | — | US | disclosed |
| US-5385842-A | Anthraquinones as inhibitors of sulfide production from sulfate-reducing bacteria | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-01-31 | — | — | US | disclosed |
| EP-0525073-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. | DU PONT (US) | 1993-02-03 | — | — | EP | disclosed |
| WO-1991015954-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-31 | — | — | WO | disclosed |
| EP-0230045-B1 | PROCESS FOR DYEING POLYAMIDE FIBRES | BAYER AG (DE) | 1991-01-16 | — | — | EP | disclosed |
| US-4773914-A | Process for trichromatic dyeing polyamide fibres | BAYER AKTIENGESELLSCHAFT (DE) | 1988-09-27 | — | — | US | disclosed |
| US-4719053-A | FOR DYES | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-01-12 | — | — | US | disclosed |
| EP-0230045-A2 | Process for dyeing polyamide fibres | BAYER AG (DE) | 1987-07-29 | — | — | EP | disclosed |
| EP-0045488-B1 | WATER-SOLUBLE FIBRE-REACTIVE COMPOUNDS AND THEIR USE IN FINISHING TEXTILES, AS WELL AS THE BETA-CHLOROETHYL-SULFONYL-METHYL-BENZOIC-ACID HALOGENIDES, AND THEIR USE AS A FIBRE-REACTIVE ANCHOR | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-06-19 | — | — | EP | disclosed |
| US-4473498-A | Water-soluble, fiber-reactive organic dyestuffs containing a β-chloro-ethylsulfonyl-methyl-benzoic acid amide group | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150119356-A1 | Ophthalmic Viscoelastic Device | UACA, ICAM1, VIM | PHLPP2 675/4885GNG2 2636/4885GNB1 2295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.